| BCBS Highmark NY and West NY | Crizanlizumab-tmca (Adakveo) | 2025-10-06 |
| BCBS Highmark Delaware | Octreotide acetate (Sandostatin, Sandostatin LAR) and Lanreotide (Somatuline Depot) | 2025-10-06 |
| BCBS Highmark Delaware | Luspatercept (Reblozyl) | 2025-10-06 |
| BCBS Highmark Delaware | Naxitamab (Danyelza) | 2025-10-06 |
| BCBS Highmark West Virginia | Transplant Rejection Testing | 2025-10-06 |
| BCBS Highmark West Virginia | Naxitamab (Danyelza) | 2025-10-06 |
| BCBS Highmark West Virginia | Octreotide acetate (Sandostatin, Sandostatin LAR) and Lanreotide (Somatuline Depot) | 2025-10-06 |
| BCBS Highmark West Virginia | Luspatercept (Reblozyl) | 2025-10-06 |
| Medicare Noridian | Billing and Coding: Wound Care & Debridement – Provided by a Therapist, Physician, NPP or as Incident-to Services (53296) | 2025-10-06 |
| Medicare Noridian | Billing and Coding: Frequency of Hemodialysis (55675) | 2025-10-06 |